336 related articles for article (PubMed ID: 2992767)
21. Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
Kobobun K; O'Donohue TL; Handelmann GE; Sawyer TK; Hruby VJ; Hadley ME
Peptides; 1983; 4(5):721-4. PubMed ID: 6657517
[TBL] [Abstract][Full Text] [Related]
22. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
Fuller BB; Lunsford JB; Iman DS
J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
[TBL] [Abstract][Full Text] [Related]
23. Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10.
Al-Obeidi F; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1989 Jan; 32(1):174-9. PubMed ID: 2535874
[TBL] [Abstract][Full Text] [Related]
24. Photoaffinity labelling of melanoma cell MSH receptors.
Scimonelli T; Eberle AN
FEBS Lett; 1987 Dec; 226(1):134-8. PubMed ID: 3691812
[TBL] [Abstract][Full Text] [Related]
25. Melanotropic peptide receptors: membrane markers of human melanoma cells.
Jiang J; Sharma SD; Fink JL; Hadley ME; Hruby VJ
Exp Dermatol; 1996 Dec; 5(6):325-33. PubMed ID: 9028794
[TBL] [Abstract][Full Text] [Related]
26. Biological activities of melanotropic peptide fatty acid conjugates.
Hadley ME; al-Obeidi F; Hruby VJ; Weinrach JC; Freedberg D; Jiang JW; Stover RS
Pigment Cell Res; 1991 Oct; 4(4):180-5. PubMed ID: 1667821
[TBL] [Abstract][Full Text] [Related]
27. alpha-MSH analogues and adrenal zona glomerulosa function.
Vinson GP; Whitehouse BJ; Bateman A; Hruby VJ; Sawyer TK; Darman PS
Life Sci; 1984 Aug; 35(6):603-10. PubMed ID: 6087070
[TBL] [Abstract][Full Text] [Related]
28. Comparative biological activities of potent active-site analogues of alpha-melanotropin. Effect of tyrosine substitution at position-4.
Wilkes BC; Sawyer TK; Hruby VJ; Hadley ME
Int J Pept Protein Res; 1984 Jun; 23(6):621-9. PubMed ID: 6332085
[TBL] [Abstract][Full Text] [Related]
29. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
Garg PK; Alston KL; Welsh PC; Zalutsky MR
Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
[TBL] [Abstract][Full Text] [Related]
30. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
31. Melanotropin structure-activity studies on melanocytes of the teleost fish, Synbranchus marmoratus.
Castrucci AM; Hadley ME; Wilkes BC; Hruby VJ; Sawyer TK
Gen Comp Endocrinol; 1989 May; 74(2):209-14. PubMed ID: 2714625
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of follicular melanogenesis in the mouse by topical and injected melanotropins.
Levine N; Lemus-Wilson A; Wood SH; Abdel Malek ZA; Al-Obeidi F; Hruby VJ; Hadley ME
J Invest Dermatol; 1987 Sep; 89(3):269-73. PubMed ID: 3624899
[TBL] [Abstract][Full Text] [Related]
33. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
[TBL] [Abstract][Full Text] [Related]
34. An improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone.
Bard DR
Nucl Med Commun; 1995 Oct; 16(10):860-6. PubMed ID: 8570117
[TBL] [Abstract][Full Text] [Related]
35. Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val).
Cody WL; Wilkes BC; Muska BJ; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1984 Sep; 27(9):1186-90. PubMed ID: 6332195
[TBL] [Abstract][Full Text] [Related]
36. Actions of melanotropins on mouse melanoma cell growth in vitro.
Abdel Malek ZA; Hadley ME; Bregman MD; Meyskens FL; Hruby VJ
J Natl Cancer Inst; 1986 May; 76(5):857-63. PubMed ID: 3009949
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
[TBL] [Abstract][Full Text] [Related]
38. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
[TBL] [Abstract][Full Text] [Related]
39. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
Lee TH; Lee MS
Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
[TBL] [Abstract][Full Text] [Related]
40. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.
Hadley ME; Anderson B; Heward CB; Sawyer TK; Hruby VJ
Science; 1981 Aug; 213(4511):1025-7. PubMed ID: 6973820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
